Breast Biopsy Devices Market Size to grow by USD 778.7 million between 2024-2028
According to a research report “ Breast Biopsy Devices Market” by Product (Biopsy needles and systems, Biopsy image-guided systems, Others) End-user (Hospitals, ASCs, Breast cancer specialty centers and clinics, Others) Modality (Stereotactic x-ray guided breast biopsy, Ultrasound-guided breast biopsy, MRI-guided breast biopsy) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 778.7 million, at a CAGR of about 10.87% during the forecast period. In the global health landscape, cancer remains a significant concern due to its high mortality rate. Among various types of cancer, breast cancer is a leading concern, particularly among the female population. According to the World Bank Group, approximately 10% of the world's female population is aged 65 and above, making this demographic more susceptible to breast cancer. Additionally, younger women, especially those with a genetic predisposition to ovarian and breast cancer or a BRCA1 and BRCA2 gene mutation, are also at an increased risk. The demand for advanced breast biopsy devices is escalating due to the growing prevalence of breast cancer across various age groups.
Browse market data tables, figures, and in-depth TOC on “Breast Biopsy Devices Market” by Product (Biopsy needles and systems, Biopsy image-guided systems, Others) End-user (Hospitals, ASCs, Breast cancer specialty centers and clinics, Others) Modality (Stereotactic x-ray guided breast biopsy, Ultrasound-guided breast biopsy, MRI-guided breast biopsy) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product, the Biopsy needles and systems segment is projected to dominate the market size in 2024
The Breast Biopsy Devices market encompasses innovative technologies and tools used in the early detection and diagnosis of breast-related diseases. These devices include vacuum-assisted biopsy systems, wireless breast biopsy systems, and stereotactic breast biopsy systems. Market growth is driven by rising breast cancer incidences, increasing awareness, and advancements in technology. Manufacturers focus on developing minimally invasive, accurate, and cost-effective solutions to cater to evolving patient needs.
By End-user, Hospitals segment is expected to hold the largest market size for the year 2024
The Breast Biopsy Devices market represents a significant growth opportunity for medical device manufacturers. This market is driven by the increasing incidence of breast cancer and the subsequent rise in diagnostic procedures. Advanced technologies, such as MRI-guided and stereotactic breast biopsy devices, offer enhanced accuracy and minimal invasiveness, making them preferred choices for both patients and healthcare providers. Market players are investing in research and development to introduce innovative products and expand their market share.
North America is forecasted to hold the largest market size by region in 2024
The Breast Biopsy Devices market represents a significant business opportunity for medical device manufacturers. These devices are essential tools for diagnosing breast-related health issues, making accurate and timely detection crucial. Market growth is driven by rising breast cancer prevalence, increasing awareness, and advancements in technology. Key players include Becton, Dickinson and Company, Hologic, and Siemens Healthineers. Market size is projected to expand at a steady CAGR through 2027.
The Breast Biopsy Devices Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Title: Breast Biopsy Devices Market: Advancements and Opportunities in Diagnosis and Treatment The Breast Biopsy Devices Market is witnessing significant growth due to the increasing incidence of breast cancer, which is the most common cancer among women worldwide. According to the World Health Organization, an estimated 2.3 million cases were diagnosed in 2020, resulting in approximately 685,000 deaths. Early diagnosis is crucial for effective treatment, leading to increased demand for breast biopsy devices in laboratories, hospitals, and surgical centers. Advancements in biotechnology and pharmaceutical research have led to the development of various breast biopsy devices, including surgical breast biopsy, needle breast biopsy, and liquid breast biopsy. These devices play a vital role in diagnosis, therapy selection, recurrence monitoring, and treatment monitoring. Laboratory supplies companies are investing in research and development to improve the accuracy and accessibility of these devices. Liquid biopsy, a non-invasive method, is gaining popularity due to its convenience and minimal invasiveness. Reimbursements for breast cancer screening and diagnostic procedures are also driving market growth. Stay updated on the latest trends, technologies, and market insights in the Breast Biopsy Devices Market. Join us for our upcoming webinar and conference to connect with industry experts and explore opportunities for collaboration.
Market Research Overview
Title: Breast Biopsy Devices Market: Advancements and Trends in Diagnosis and Treatment The Breast Biopsy Devices Market encompasses a range of tools and technologies used for the diagnosis and treatment of breast cancer. This market includes laboratory supplies such as assay kits, localization wires, biopsy tables, guidance systems, biopsy needles, and other related devices. The market is driven by the increasing incidence of breast cancer, which is the most common cancer among women, and the need for early detection and accurate diagnosis. Treatment accessibility in hospitals, research laboratories, and surgical centers is a key factor fueling market growth. Advancements in biotechnology and pharmaceutical research have led to breakthrough techniques like liquid breast biopsy, which allows for the collection of DNA fragments and circulating tumor cells from the bloodstream for diagnosis and recurrence monitoring. Skilled healthcare professionals, including surgeons, play a crucial role in the successful implementation of various biopsy techniques, such as needle breast biopsies and surgical breast biopsies. The complexity of tumors and the need for therapy selection and treatment monitoring have further increased the demand for advanced biopsy devices. Clinical trials and reimbursements continue to shape the Breast Biopsy Devices Market, with a focus on improving patient outcomes and reducing the need for needle reuse. The market is also witnessing a surge in interest from healthcare professionals and organizations, as evidenced by the growing number of webinars and conferences on the topic. In summary, the Breast Biopsy Devices Market is a dynamic and evolving field, with a significant impact on the diagnosis and treatment of early and invasive breast cancers. The market is expected to continue growing as new technologies and techniques emerge, improving accessibility and accuracy while reducing the burden of breast cancer on patients and healthcare systems.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
